Drug profile · INN
doxecitine
KYGEVVI
doxecitine (KYGEVVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
FDA: approved EMA: approved Alimentary tract and metabolism (A16) A16AX29
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — doxecitine
- US status
- approved
- Class
- Alimentary tract and metabolism (A16)
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
doxecitine (KYGEVVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN doxecitine
Brand KYGEVVI
Therapeutic class Alimentary tract and metabolism (A16)
Route ORAL
Formulation FOR SOLUTION
ATC code A16AX29
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is doxecitine?
doxecitine (KYGEVVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for doxecitine?
KYGEVVI is a marketed brand name for doxecitine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of doxecitine?
doxecitine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.